Abstract

Cryopreservation of mature oocytes and embryos has provided numerous benefits in reproductive medicine. Although successful cryopreservation of germinal-vesicle stage (GV) oocytes holds promise for further advances in reproductive biology and clinical embryology fields, reports regarding cryopreservation of immature oocytes are limited. Oocyte survival and maturation rates have improved since vitrification is being performed at the GV stage, but the subsequent developmental competence of GV oocytes is still low. The purpose of this study was to evaluate the effects of supplementation of the maturation medium with cyclic adenosine monophosphate (cAMP) modulators on the developmental competence of vitrified-warmed GV bovine oocytes. GV oocytes were vitrified-warmed and cultured to allow for oocyte maturation, and then parthenogenetically activated or fertilized in vitro. Our results indicate that addition of a cAMP modulator forskolin (FSK) or 3-isobutyl-1-methylxanthine (IBMX) to the maturation medium significantly improved the developmental competence of vitrified-warmed GV oocytes. We also demonstrated that vitrification of GV oocytes led to a decline in cAMP levels and maturation-promoting factor (MPF) activity in the oocytes during the initial and final phases of maturation, respectively. Nevertheless, the addition of FSK or IBMX to the maturation medium significantly elevated cAMP levels and MPF activity during IVM. Taken together, our results suggest that the cryopreservation-associated meiotic and developmental abnormalities observed in GV oocytes may be ameliorated by an artificial increase in cAMP levels during maturation culture after warming.

Highlights

  • The developmental competence of oocytes has been improved by modulation of cyclic adenosine monophosphate levels during in vitro maturation (IVM) [1]

  • The present study demonstrates that vitrification of germinal-vesicle stage (GV) oocytes causes a decline in cyclic adenosine monophosphate (cAMP) levels inside oocytes and low maturation-promoting factor (MPF) activity after IVM culture

  • High cAMP levels were observed in fresh GV oocytes after retrieval, but these levels declined after vitrification/warming

Read more

Summary

Introduction

The developmental competence of oocytes has been improved by modulation of cyclic adenosine monophosphate (cAMP) levels during in vitro maturation (IVM) [1]. A recent study showed that modulation of cAMP content during the first 1–2 h after oocyte collection is critical for oocyte development, and that this regulation can be achieved by treatment with an adenylate cyclase activator or a nonspecific phosphodiesterase inhibitor, e.g., forskolin (FSK) or 3-isobutyl1-methylxanthine (IBMX). After this treatment, cAMP levels increase and a loss of gap junctions and resumption of meiosis are prevented synergistically, resulting in increased developmental competence [12,13,14]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call